OLMA Stock Summary and Trading Ideas (Olema Pharmaceuticals | NASDAQ:OLMA)

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Olema Pharmaceuticals trades on the NASDAQ stock market under the symbol OLMA.

As of March 12, 2026, OLMA stock price declined to $14.91 with 1,407,576 million shares trading.

OLMA has a beta of 0.81, meaning it tends to be less sensitive to market movements. OLMA has a correlation of 0.01 to the broad based SPY ETF.

OLMA has a market cap of $1.20 billion. This is considered a Small Cap stock.

In the last 3 years, OLMA traded as high as $36.26 and as low as $2.86.

The top ETF exchange traded funds that OLMA belongs to (by Net Assets): VTI, IWM, XBI, VXF, IWN.

OLMA has outperformed the market in the last year with a return of +230.6%, while the SPY ETF gained +20.5%. However, in the most recent history, OLMA shares have underperformed the stock market with its stock returning -54.9% in the last 3 month period and -38.9% for the last 2 week period, while SPY has returned -2.0% and -3.4%, respectively.

OLMA support price is $14.85 and resistance is $16.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OLMA shares will trade within this expected range on the day.